Skip navigation
Skip navigation

Intravesical gemcitabine versus intravesical bacillus calmette-guerin for the treatment of non-muscle invasive bladder cancer: An evaluation of efficacy and toxicity

Prasanna, Thiru; Craft, Paul; Balasingam, Gayathri; Haxhimolla, Hodo; Pranavan, Ganesalingam


Background: Intravesical Bacillus Calmette–Guérin (BCG) remains the standard adjuvant treatment for non-muscle invasive bladder cancer (NMIBC) following transurethral resection; however, BCG failure and related toxicities are common. Objectives: To compare the efficacy and toxicity of intravesical BCG and gemcitabine in the treatment of NMIBC. Methods: Retrospective data were collected in the region of Canberra, Australia from January 2010 to December 2015. The survival cutoff was December...[Show more]

CollectionsANU Research Publications
Date published: 2017
Type: Journal article
Source: Frontiers in Oncology
DOI: 10.3389/fonc.2017.00260
Access Rights: Open Access


File Description SizeFormat Image
01_Prasanna_Intravesical_gemcitabine_2017.pdf261.92 kBAdobe PDFThumbnail

This item is licensed under a Creative Commons License Creative Commons

Updated:  17 November 2022/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator